NCT03546582
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03546582
Title SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma (KEYSTROKE)
Acronym KEYSTROKE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors RTOG Foundation, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Arizona Cancer Center - North Campus Tucson Arizona 85719 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Cleveland Clinic - Weston Weston Florida 33331 United States Details
University of Louisville, James Graham Brown Cancer Center Louisville Kentucky 40202 United States Details
Boston Medical Center Boston Massachusetts 02118 United States Details
Washington University St. Louis St Louis Missouri 63110 United States Details
Northwell Health Lake Success New York 11042 United States Details
University of Cincinnati Cancer Center - UC Medical Center Cincinnati Ohio 45219 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
University of Pittsburgh Medical Center Shadyside Pittsburgh Pennsylvania 15232 United States Details
University of Texas Southwestern Dallas Texas 75390 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Centre Hospitalier de l'université de Montréal Montreal Quebec H2X 3E4 Canada Details
McGill University Montreal Quebec H4A 3J1 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field